Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registry [MIR]).

PubWeight™: 0.90‹?›

🔗 View Article (PMID 11348599)

Published in Am J Cardiol on May 01, 2001

Authors

K Dönges1, R Schiele, A Gitt, H Wienbergen, S Schneider, R Zahn, R Grube, B Baumgärtel, H G Glunz, J Senges, Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) Study Groups

Author Affiliations

1: Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany. K.Doenges@t-online.de

Articles by these authors

A simulated annealing approach to define the genetic structure of populations. Mol Ecol (2002) 5.34

The metabolically obese, normal-weight individual revisited. Diabetes (1998) 3.52

Why hunter-gatherer populations do not show signs of pleistocene demographic expansions. Proc Natl Acad Sci U S A (1999) 2.58

NMR structure of the bovine prion protein. Proc Natl Acad Sci U S A (2000) 2.56

The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes. EMBO J (1998) 2.49

SIMCOAL: a general coalescent program for the simulation of molecular data in interconnected populations with arbitrary demography. J Hered (2001) 2.45

Lung function and exercise gas exchange in chronic heart failure. Circulation (1997) 2.32

Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol (1998) 2.19

Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J (1999) 2.13

ClpS is an essential component of the N-end rule pathway in Escherichia coli. Nature (2006) 2.09

Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society. Neurology (2000) 2.09

Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics (2001) 1.91

Portal-systemic encephalopathy in the noncirrhotic patient. Effect of portal-systemic shunting. Arch Surg (1973) 1.91

Suppression of defective RAS1 and RAS2 functions in yeast by an adenylate cyclase activated by a single amino acid change. EMBO J (1986) 1.90

Failure of electroencephalography to diagnose brain death in comatose children. Ann Neurol (1979) 1.88

Chromophore structure of the physiologically active form (P(fr)) of phytochrome. Proc Natl Acad Sci U S A (1983) 1.87

Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia. Brain (2009) 1.82

Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J Am Coll Cardiol (2001) 1.82

A structural model for GroEL-polypeptide recognition. Proc Natl Acad Sci U S A (1997) 1.82

Women in academic emergency medicine. Acad Emerg Med (2000) 1.70

PTCA registry of German community hospitals. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) Study Group. Eur Heart J (1997) 1.69

Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR). Eur Heart J (2001) 1.69

The WASp homologue Las17p functions with the WIP homologue End5p/verprolin and is essential for endocytosis in yeast. Curr Biol (1998) 1.68

Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Am Heart J (1999) 1.66

A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA). Vox Sang (2006) 1.64

The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart (2010) 1.64

Pseudoaneurysm after cardiac catheterization: therapeutic interventions and their sequelae: experience in 86 patients. Cathet Cardiovasc Diagn (1997) 1.62

Evaluation of enzyme-linked immunoassay for serological diagnosis of cysticercosis. J Clin Microbiol (1995) 1.61

Preventing post-treatment bacteremia: comparing topical povidone-iodine and chlorhexidine. J Am Dent Assoc (1995) 1.50

Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J Mol Biol (2000) 1.49

Conditions for interference versus facilitation during sequential sensorimotor adaptation. Exp Brain Res (2001) 1.47

Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). J Invasive Cardiol (2001) 1.46

Brain death in the newborn. Pediatrics (1989) 1.46

Sunbed use in Germany: trends, user histories and factors associated with cessation and readiness to change. Br J Dermatol (2013) 1.45

The patient with acute myocardial infarction who does not receive reperfusion treatment. Heart (2001) 1.43

Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res (1999) 1.43

Neural reorganization underlies improvement in stroke-induced motor dysfunction by music-supported therapy. Ann N Y Acad Sci (2009) 1.42

The 60 Minutes Myocardial Infarction Project. Characteristics on admission and clinical outcome in patients with reinfarction compared to patients with a first infarction. Eur Heart J (1998) 1.42

Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol Cell Biol (1999) 1.42

Effects of refeeding by cyclic enteral nutrition on body composition: comparative study of elderly and younger patients. Clin Nutr (1997) 1.41

Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease. Blood Coagul Fibrinolysis (2002) 1.41

O6-methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary. Cancer Res (1991) 1.41

Local drug delivery via transvascular injection. J Invasive Cardiol (1999) 1.40

Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Heart (1999) 1.39

Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Catheter Cardiovasc Interv (1999) 1.39

[Long-term therapy after an acute myocardial infarct]. Dtsch Med Wochenschr (1992) 1.39

[Diagnosis of pulmonary embolism]. Dtsch Med Wochenschr (1996) 1.38

Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study). Circulation (2001) 1.38

Impairment of inhibitory control in response to food-associated cues and attentional bias of obese participants and normal-weight controls. Int J Obes (Lond) (2011) 1.37

The junction-associated protein AF-6 interacts and clusters with specific Eph receptor tyrosine kinases at specialized sites of cell-cell contact in the brain. J Cell Biol (1999) 1.33

"Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry. Z Kardiol (2004) 1.28

NMR structures of three single-residue variants of the human prion protein. Proc Natl Acad Sci U S A (2000) 1.28

Buying your first PDA. Fam Pract Manag (2001) 1.28

Ultralong dephasing time in InGaAs quantum dots. Phys Rev Lett (2001) 1.25

Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J Mol Biol (1995) 1.24

Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci U S A (1997) 1.18

Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation. J Mater Sci Mater Med (2005) 1.15

Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J (1984) 1.14

The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus. Diabetologia (1999) 1.14

You Can Control Asthma: evaluation of an asthma education program for hospitalized inner-city children. Patient Educ Couns (1991) 1.14

Practice parameter: treatment of the child with a first unprovoked seizure: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology (2003) 1.13

Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia. Leukemia (2011) 1.12

Mammalian skeletal muscle: reduced chloride conductance in drug-induced myotonia and induction of myotonia by low-chloride solution. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.10

Imaging ROMK1 inwardly rectifying ATP-sensitive K+ channel protein using atomic force microscopy. Proc Natl Acad Sci U S A (1996) 1.09

The glucocorticoid receptor is associated with the RNA-binding nuclear matrix protein hnRNP U. J Biol Chem (1997) 1.09

Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J Virol (2005) 1.09

Refolding chromatography with immobilized mini-chaperones. Proc Natl Acad Sci U S A (1997) 1.09

Commentary on "A study of the workforce in emergency medicine". Society for Academic Emergency Medicine. Ann Emerg Med (1999) 1.08

Home environmental risk factors in urban minority asthmatic children. Ann Allergy (1994) 1.08

Energy expenditure in ball games for wheelchair users. Spinal Cord (2008) 1.07

[Imaging of the hip joint hyaline cartilage with MR tomography using a gradient echo sequence with fat-water phase coherence]. Rofo (1990) 1.07

Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi. Int J Tuberc Lung Dis (2001) 1.07

Virtual DNA analysis--a new tool for combination and standardised evaluation of SSO, SSP and sequencing-based typing results. Tissue Antigens (1998) 1.07

[Standards, options and recommendations: nutritional support in palliative or terminal care of adult patients with progressive cancer]. Bull Cancer (2001) 1.07

[Clinical use of an expert system for interpreting lung function tests--relation of results to the respective examiner]. Pneumologie (1990) 1.06

Presynaptic depolarization of cutaneous mechanoreceptor afferents after mechanical skin stimulation. Exp Brain Res (1967) 1.05

Differential induction of enzymes involved in anaerobic metabolism of aromatic compounds in the denitrifying bacterium Thauera aromatica. Arch Microbiol (1998) 1.05

Cavity QED with magnetically coupled collective spin states. Phys Rev Lett (2011) 1.05

Cloning and characterization of UXT, a novel gene in human Xp11, which is widely and abundantly expressed in tumor tissue. Genomics (1999) 1.05

Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol (2014) 1.04